<DOC>
	<DOCNO>NCT02571738</DOCNO>
	<brief_summary>A Multicenter , Randomized , Single-Blind Study Open-Label Extension Option Further Evaluate Safety Efficacy Cryopreserved Human Amniotic Membrane Treatment Chronic Diabetic Foot Ulcers</brief_summary>
	<brief_title>Study Evaluate Safety Efficacy CHAM* Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Between 18 year 80 year age inclusive , date screen 2 . Confirmed diagnosis Type I Type II Diabetes 3 . An Index Ulcer define chronic ( presence wound &gt; 4 week ) , present 52 week Screening Visit 4 . Index Ulcer locate malleoli plantar dorsal surface foot 5 . The Index Ulcer 1 cm2 15 cm2 , inclusive , Screening Visit 6 . The Index Ulcer extend dermis subcutaneous tissue without evidence expose muscle , tendon , bone , joint capsule 7 . Wound free necrotic debris 8 . Patient adequate circulation foot document either : Ankle Brachial Index ( ABI ) &gt; 0.70 &lt; 1.30 , In patient noncompressible ankle vessel define ABI ≥ 1.30 , Toe Brachial Index ( TBI ) ≥ 0.50 , In patient noncompressible ankle vessel define ABI ≥ 1.30 TBI perform ( e.g. , toe absent , wound present , site perform TBI ) , Doppler waveform posterior tibial dorsalis pedis artery ankle consistent adequate flow foot ( biphasic triphasic ) diagnostic confirmation adequate flow ( e.g. , duplex imaging , normal pulse volume record [ PVR ] test ) . 1 . Index Ulcer nondiabetic pathophysiology 2 . Gangrene present part affect foot 3 . Index Ulcer active Charcot deformity 4 . The long dimension Index Ulcer exceed 5 cm Baseline Visit 5 . Patient currently receive dialysis planning go dialysis 6 . Patient 2 previous diseaserelated amputation low extremity 7 . Patient glycated hemoglobin A1c ( HbA1c ) level &gt; 10 % 8 . Chronic oral steroid use &gt; 7.5 mg daily longer 3 month time screen 9 . Patient receive IV corticosteroid , immunosuppressive cytotoxic agent time screen 10 . Requiring intravenous ( IV ) antibiotic treat index wound infection time screen 11 . Patient ulcer within 5 cm Index Ulcer identify study consideration 12 . Patient Human Immunodeficiency Virus ( HIV ) positive Acquired Immune Deficiency Syndrome ( AIDS ) 13 . Current evidence cellulitis , evidence infection include fever pu drainage wind site 14 . Current evidence osteomyelitis history osteomyelitis within 30 day screen 15 . Patient active malignancy nonmelanoma skin cancer 16 . Patient 's Index Ulcer decrease ≥20 % 1week screening period 17 . Patient 's random blood sugar &gt; 350 mg/dl screen 18 . Patient untreated alcohol substance abuse time screen 19 . Pregnant woman woman breastfeed 20 . Patient currently enrol participate another investigational device , drug , biological trial within 30 day screen 21 . Patient within last 30 day , currently undergo , plan wound treatment growth factor , live skin , dermal substitute advance biological therapy 22 . Patient employee , immediate family member employee , sponsor company site research staff conduct study 23 . Patients already randomize Protocol 303 center may consider screen reentry trial center , even end followup period 24 . Patients history poor compliance , unwillingness inability adhere requirement protocol .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>